Solicitation-Radiopharmaceuticals -Evans Army Community Hospital
ID: W81K0024Q0167Type: Solicitation
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW40M USA HCAJBSA FT SAM HOUSTON, TX, 78234-4504, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/b4188de5707846188523839f573d18fb/view
Timeline
    Description

    The Evans Army Community Hospital in Fort Carson, Colorado, is seeking radiopharmaceuticals through a federal contract. The main purpose of this solicitation, W81K00-24-Q-0167, is to obtain these specialized pharmaceuticals for the hospital's needs.

    Scope of Work

    The successful awardee will be responsible for supplying radiopharmaceuticals as outlined in the attached Statement of Work (SOW). The SOW details the specific requirements and expectations, including the delivery of a comprehensive range of radiopharmaceuticals. Awardees will need to provide pricing information for the products listed in the attached RPH Product List.

    Eligibility Criteria

    Eligible applicants for this opportunity should have expertise and experience in the pharmaceutical industry, specifically in manufacturing and supplying radiopharmaceuticals. The ability to comply with the specific requirements outlined in the SOW and meet the pricing expectations is crucial.

    Funding and Contract Details

    The contract type is not specified in the provided information. However, the notice emphasizes the importance of reviewing the relevant FAR (Federal Acquisition Regulation) addenda for instructions and evaluation criteria. The estimated funding for this contract is not available in the provided information.

    Submission Process

    Offerors are required to submit their questions by email, with a copy to both the primary and secondary contact, by the deadline of 10:00 AM (Mountain) on July 31, 2024. The submissions should refer to the attached documents, specifically the SOW and RPH Product List, when crafting their proposals.

    Evaluation Criteria

    The evaluation of offers will be based on the guidelines outlined in the FAR 52.212-1 and FAR 52.212-2 addenda. The specific evaluation criteria are not provided in the information supplied, but typically include factors such as price, technical merit, and past performance.

    Contact Information

    For any questions or clarifications, offerors should contact the primary contact, Fabiola Palma-Trujillo, via email at fabiola.palma-trujillo.civ@health.mil. Ms. Robyn Villafranco should also be copied on all communications (email: Robyn.A.Villafranco.civ@health.mil).

    Please note that the above summary is based on the information provided and may not cover all the nuances of the opportunity. For a comprehensive understanding, carefully review the attached documents referenced in the opportunity listing.

    Point(s) of Contact
    Fabiola Palma-Trujillo
    fabiola.palma-trujillo.civ@health.mil
    Robyn Villafranco
    Robyn.A.Villafranco.civ@health.mil
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Solicitation-Radiopharmaceuticals -Evans Army Community Hospital
    Currently viewing
    Solicitation
    Similar Opportunities
    6505--PET MRI Radiopharmaceuticals
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to enter into a sole source procurement for PET MRI Radiopharmaceuticals for the John D. Dingell VA Medical Center in Detroit, MI. This contract will provide essential radiopharmaceuticals necessary for conducting nuclear medicine exams on PET MRI patients, with a one-year purchase order scheduled from October 1, 2024, to September 30, 2025. The procurement includes specific products such as Cu64 Dotatate, F18 PSMA, F18 FDG, and F18 Vizamyl, with estimated annual quantities outlined in the opportunity. Interested parties may express their interest and demonstrate their capability to meet the requirements by the deadline of September 17, 2024, by contacting Contracting Officer Jeffrey Rozema at jeffrey.rozema@va.gov.
    Q522--PHARMACUTICAL, STL 657-24-3-1642-0121, (VA-25-00001168)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking responses to a Sources Sought Notice for a contract involving the provision of a proprietary radiopharmaceutical agent, Pluvicto, for the St. Louis VA Medical Center. This contract will cover a base year plus four option years for the supply of Lutetium LU 177 Vipivvotide Tetraxetan, which is critical for treating adult patients with prostate-specific membrane antigen (PSMA) positive metastatic castration-resistant prostate cancer. The selected contractor will be responsible for administering this radioactive diagnostic therapy via IV, with all contract administration functions retained by the Department of Veterans Affairs. Interested parties must submit their responses by September 20, 2024, at 3:00 PM CST, to Michael P. Murphy at michael.murphy7@va.gov, including their Unique Entity ID and relevant qualifications.
    6505--Supply, Axumin-Axumin + Cerianna Medicines - Nuclear Med, CLE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to solicit and negotiate exclusively with PetNet Solutions and TrillaMed for the supply of three proprietary radiopharmaceuticals—Axumin, Amyvid, and Cerianna—for the Nuclear Medicine Service at the Louis Stokes Cleveland VA Medical Center. These products are critical for diagnosing recurrent prostate cancer, breast cancer, and Alzheimer’s disease, necessitating the use of a local radiopharmacy due to their radioactive nature and short shelf life. Interested vendors may submit their capabilities until September 18, 2024, to determine if a competitive procurement process is feasible, with all inquiries directed to Contract Specialist Don Caldwell at don.caldwell@va.gov.
    Teleradiology Services for VASNHCS
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for Teleradiology Services for the Veterans Affairs Southern Nevada Health Care System (VASNHCS). The contract requires certified or board-eligible radiology physicians to provide remote diagnostic imaging services, including CT, MRI, and ultrasound scans, in accordance with strict American College of Radiology standards. This procurement is critical for ensuring timely and accurate diagnostic services for veterans, with an estimated total contract value of $19 million over the performance period from December 1, 2024, to November 30, 2029. Interested vendors should contact Maricela A Berrones-Gauger at maricela.berrones-gauger@va.gov for further details and to submit proposals, adhering to the Service-Disabled Veteran-Owned Small Business (SDVOSB) set-aside requirements.
    Lab Radiological Sample Analysis Contract
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking proposals for a Lab Radiological Sample Analysis Contract to support the Defense Centers for Public Health - Aberdeen (DCPH-A). This contract involves the non-personal services requirement for the analysis of radiological samples across various parameters, which is crucial for enhancing public health readiness and ensuring the quality of the Public Health Enterprise. The solicitation is prepared in accordance with Federal Acquisition Regulation (FAR) guidelines, and interested vendors are encouraged to submit quotes as no written solicitation will be issued. For further details, potential bidders can contact Kenneth Grenier at kenneth.e.grenier2.civ@health.mil or by phone at 301-619-2728.
    J065--Support and licensing required to maintain the Philips ISCV cardiology PACS system.
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Veterans Health Administration's Network Contracting Office 19, is seeking qualified sources for support and licensing to maintain the Philips ISCV cardiology PACS system for the Rocky Mountain Regional VA Medical Center. The procurement aims to ensure effective operation and maintenance of the ISCV system, which is critical for managing cardiology imaging and data within the healthcare environment. Interested vendors are required to submit their company information, including business classification and responses to qualifying questions, by September 18, 2024, at 4:00 PM MST. For further inquiries, potential respondents can contact Contract Specialist Natasha Holland at natasha.holland@va.gov or by phone at 303.712.5753.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Active
    Dept Of Defense
    The Department of Defense (DoD) is issuing a Request for Quotation (RFQ) for the establishment of Blanket Purchase Agreements (BPA) and Additional Discount Program (ADP) agreements related to pharmaceutical agents under the Defense Health Agency's Uniform Formulary (UF). This procurement aims to secure pricing agreements for various newly approved drugs, including those in the classes of Parkinson's agents, gastrointestinal agents, respiratory agents, hematological agents, targeted immunomodulatory biologics, anticonvulsants, and oncological agents, which will be reviewed during the Pharmacy and Therapeutics (P&T) Committee meeting scheduled for November 6-7, 2024. The initiative is crucial for maintaining an effective pharmacy benefits program for the Military Health System (MHS), ensuring that military personnel have access to high-value medications while adhering to cost-effectiveness criteria. Interested manufacturers must submit their quotes by September 19, 2024, and can direct inquiries to primary contact Stephanie Erpelding at stephanie.j.erpelding.civ@health.mil or secondary contact Tracy Banks at tracy.e.banks2.civ@health.mil.
    Piflufolastat F-18 injection drugs (Pylarify) from Sofie Co. (Notice of Intent to sole source)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to negotiate a sole-source contract with Sofie Co. for the procurement of Piflufolastat F-18 injection drugs (Pylarify) essential for clinical nuclear medicine procedures at the NIH Clinical Center. This acquisition aims to secure compounded, patient-ready doses of the radiopharmaceutical, which is critical for diagnosing and treating diseases in accordance with patient care protocols. The drugs are FDA-approved and must be compounded and delivered on a time-sensitive basis due to their rapid radiation decay, making Sofie Co. the only authorized provider capable of meeting these specialized requirements. Interested parties may submit capability statements by September 18, 2024, to Lu Chang at lu-chang.lu@nih.gov, as this is not a request for proposals.
    Q522--Teleradiology Physician Services - VANEOHS
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking Teleradiology Physician Services for the Northeast Ohio Healthcare System (VANEOHS) to provide 24/7 interpretations of Diagnostic Imaging procedures, along with in-house IT support. This procurement will consist of five one-year ordering periods, reflecting the VA's commitment to enhancing healthcare delivery through specialized remote radiology services. The solicitation for these services is expected to be available on or about September 20, 2024, with a response deadline set for October 18, 2024, at 2:00 PM Eastern Time. Interested parties can contact Contracting Specialist Karen Williams at Karen.Williams4@va.gov or by phone at 614-257-5220 for further details.
    6505--Abiraterone Acetate Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for the procurement of Abiraterone Acetate Tablets, identified by solicitation number 36E79724R0023. This procurement aims to secure a reliable supply of these pharmaceutical products for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare entities, emphasizing the need for uninterrupted supply and compliance with specific labeling and packaging requirements. The estimated annual requirements include 71,997 bottles of 120-count 250mg tablets and 1,102 bottles of 60-count 500mg tablets, with the RFP scheduled for electronic release on approximately September 18, 2024, and a closing date of October 2, 2024. Interested vendors can direct inquiries to Contract Specialist Richard Mahario at Richard.Mahario@va.gov or by phone at 708-786-5247, and must regularly check SAM.gov for updates as no paper copies of the solicitation will be provided.